Unique business model

About M1 Kliniken AG

M1 Kliniken AG is the leading provider of beauty medical health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality standards. Under the brand "M1 Med Beauty", beauty medical treatments are currently offered at more than 35 specialist centres. With six operating theatres and 35 beds, the M1 Schlossklinik für plastische und ästhetische Chirurgie in Berlin is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been driving forward its internationalisation and is currently also active in Austria, Switzerland, the Netherlands, England and Australia. In addition, the Group markets high-quality products under the brands "M1 Select" and "M1 Aesthetics" to private customers as well as doctors, pharmacies and wholesalers.


Strategy & goals

The strategic goal of the M1 Kliniken Group is to offer high quality medical services. Beauty products, beauty treatments and aesthetic surgeries are subject to high price sensitivity. The German Society for Consumer Research (GfK) has identified that the average market prices for breast surgery, liopsuction and wrinkle treatment are too expensive from the customer's point of view. The range of products and services offered by M1 Kliniken Group is therefore based on the price expectations of customers. By offering the highest quality at the best price, the demand for beauty treatments and aesthetic surgeries is increasing and new customer groups are being established.

Latest news

| Investor News

  • Management is open to interested parties
  • Valuations in the peer group of up to 30 times the annual EBITDA
  • M1 Kliniken AG expects EBITDA of over EUR 27 million in 2024

| Investor News

By acquiring the German Nutri Care GmbH and its wholly-owned subsidiary, the Dutch online pharmacy "Direct Apotheke Venlo B.V.," M1 Kliniken AG (ISIN: DE000A0STSQ8) taps into a significant growth field and expands the value chain of its health services. Direct Apotheke Venlo B.V., based in Maasbree (NL), is one of the rapidly growing providers in the online pharmacy business for aesthetic pharmaceuticals, with current core markets in Germany and the Netherlands. In the fiscal year 2022, the company recorded double-digit million-euro revenues and continues on a growth trajectory.

| Investor News

  • Group sales increase by over 10% to EUR 236.6 million in the first nine months of the 2023 financial year (previous year: EUR 214.2 million).

  • Group EBITDA increases by over 55% from EUR 10.9 million to EUR 16.9 million.

  • The operating result (Group EBIT) increases by over 98% to EUR 12.9 million (previous year: EUR 6.5 million).

  • Beauty segment: sales increase of 28.5% to EUR 53.2 million (previous year: EUR 41.4 million) and sharp rise in the Beauty EBIT margin from 8.2% to 23.5%

| Investor News

  • 20th Location outside Germany opened in Bucharest, Romania
  • Break-even expected for foreign locations within the next 12 months
  • Subsidiary established in the USA: Market entry into the world's largest market for beauty medicine expected in 2024